Drugs "same price in the same city" shuffle pharmaceutical market drug companies

The business club reported on December 2 that pharmaceuticals sold by public medical institutions at Grade 2 or above in Beijing have adopted the same price in the same city, but in the centralized tender for the same price in the same city, the situation of large and small pharmaceutical companies is significantly different. According to the relevant person in charge of the Beijing Municipal Health Bureau, a total of more than 40,000 quality products were involved in the centralized procurement of drugs, 26,000 of the competitive drugs were awarded, and the large-scale pharmaceutical companies had a higher bid rate. The share of large pharmaceutical companies was 70%. about. Analysis of the industry, centralized tendering is an important channel for drug companies to sell, if you lose this position, the future of small and medium-sized pharmaceutical companies will face a new round of reshuffle.

Since last December, Beijing has launched a unified tender for drug prices and has merged six previous tenders for Grade 2 or above hospitals. A total of 26,292 pharmaceutical products have won the bid. The same pharmaceuticals from the same company and medical institutions at Grade 2 and above perform uniform purchase prices. , sales price, so that drugs "the same price in the same city."

According to the statistics of the Municipal Health Bureau, among the successful bidders, annual sales of over 100 million yuan accounted for 72%. Guo Jinhe, deputy inspector of the Municipal Health Bureau, frankly stated that he has chosen more large drug companies, "mainly considering that the quality of medicines produced by large-scale enterprises is more assured."

“Tender bidding is an important channel for sales of pharmaceutical companies. If this position is gone, the days of SMEs will be hard for us.” Sun Dongdong, a member of the expert committee of the Ministry of Health and a professor at Peking University Law School, believes that large-scale pharmaceutical companies will focus on winning bids and make small parts Enterprises shut down and switch, and even gradually "dead", "small pharmaceutical companies to adjust the scale of production and reasonable restructuring, in the long run is conducive to the development of China's pharmaceutical and health services."

It is understood that China currently owns 4,607 pharmaceutical enterprises, and its total output value accounts for 5% of the world's total. There are only more than 70 pharmaceutical companies in the United States, but the output value accounts for 20% of the world's total. "Some small pharmaceutical companies cannot achieve independent research and development. They can only produce medicines by purchasing formulas and patents. Sometimes they even produce 'high-quality' products. If this phenomenon persists for a long time, it will certainly defeat the entire pharmaceutical industry in China." Sun Dongdong Say.

related news

The hospital paid 3.6 billion yuan for the same price in the same city

According to Shangbao News, the deputy inspector of the Beijing Municipal Health Bureau, Guo Jinhe, said yesterday that the implementation of medicines “has the same price in the same city”, with the average price of the winning bid products falling by 16% over the current market, and centralized purchasing is expected to make 3.6 billion yuan in profits to the society each year. From a public hospital, "at present, there is no increase in subsidies for public hospitals because of the same price in the same city, and the relevant policies will surely be introduced in the future."

“The prices of most commonly used drugs have decreased by 10% to 16%, and some have seen even greater reductions.” In an interview with reporters, Wang Yuqin, director of the pharmacy department of Beijing Xuanwu Hospital, cited the price drop of simvastatin per box for lowering blood lipids. More than 50%, enalapril treatment of hypertension decreased even as high as 71%.

“Now the pharmacy service fee has not yet come up. The share of the same city drug” to the people is our responsibility. Before the government introduces any relevant subsidy measures, the loss of public hospitals will surely increase.” The person in charge of the public hospital told the reporter that at the beginning of this year, the municipal health bureau conducted project costing on 8 general hospitals in Chaoyang and Xuanwu and discovered that among the 18257 college-level projects, the loss-making projects accounted for about 57%. With the same price as the city's Rangli, the amount of losses may increase."

"Although the health sector has not yet increased subsidies for public hospitals for the same price in the same city, it will surely introduce relevant policies to ease the loss of public hospitals." Guo Jinhe said that public hospital reform involves a wide range of Large compensation is difficult to achieve the goal of medical reform to solve the “difficult to see a doctor, expensive to see a doctor”, but lowering drug prices is one of the important measures for medical reforms to be successful.